COPD Stock Overview
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 4/6 |
CompuGroup Medical SE & Co. KGaA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €28.88 |
52 Week High | €50.60 |
52 Week Low | €28.88 |
Beta | 1.0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -41.57% |
3 Year Change | -62.07% |
5 Year Change | -51.05% |
Change since IPO | 52.76% |
Recent News & Updates
Recent updates
Shareholder Returns
COPD | GB Healthcare Services | GB Market | |
---|---|---|---|
7D | 0% | -0.06% | 2.2% |
1Y | -41.6% | 52.5% | 0.9% |
Return vs Industry: COPD underperformed the UK Healthcare Services industry which returned 64.1% over the past year.
Return vs Market: COPD underperformed the UK Market which returned 0.6% over the past year.
Price Volatility
COPD volatility | |
---|---|
COPD Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 8.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: COPD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine COPD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 9,199 | Michael Rauch | www.cgm.com |
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company’s Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies.
CompuGroup Medical SE & Co. KGaA Fundamentals Summary
COPD fundamental statistics | |
---|---|
Market cap | €1.46b |
Earnings (TTM) | €45.92m |
Revenue (TTM) | €1.23b |
31.7x
P/E Ratio1.2x
P/S RatioIs COPD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
COPD income statement (TTM) | |
---|---|
Revenue | €1.23b |
Cost of Revenue | €813.16m |
Gross Profit | €414.75m |
Other Expenses | €368.84m |
Earnings | €45.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
Earnings per share (EPS) | 0.88 |
Gross Margin | 33.78% |
Net Profit Margin | 3.74% |
Debt/Equity Ratio | 106.2% |
How did COPD perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield114%
Payout RatioDoes COPD pay a reliable dividends?
See COPD dividend history and benchmarksCompuGroup Medical SE KGaA dividend dates | |
---|---|
Ex Dividend Date | May 23 2024 |
Dividend Pay Date | May 27 2024 |
Days until Ex dividend | 27 days |
Days until Dividend pay date | 31 days |
Does COPD pay a reliable dividends?
See COPD dividend history and benchmarks